4
Tetrahedron Letters
a = 5.9047(2)Å, b = 2.5394(6)Å, c = 21.3951(9)Å, V = 1584.12(11)Å3, Z
References and notes
= 4, c= 1.349 g.cm3, F(0 0 0) = 672, crystal size: 0.52 x 0.18 x 0.14 mm.
Crystal structure analysis: for (R)-2-(2-chloroquinolin-3-yl)-2-[N-(S)--
methylbenzylamino]carboxamide (6j): C19H18ClN3O, Mr = 339.81 g.
mol-1, monoclinic, space group P21(4), a = 9.2574(2) Å, b = 6.6265(2) Å,
c = 14.2529(4) Å, = 104.0370(10)°, V = 848.22(4) Å3, Z = 2, ρc=1.33
1. (a) Amino Acids, Peptides and Proteins in Organic Chemistry, Hughes,
A.B. Ed., Wiley-VCH, Weinheim, 2011. (b) Asymmetric Synthesis and
Application of -Amino Acids; Soloshonok, K.; Izawa, V. A. Eds., ACS.
Symposium series 1009, ACS: Washington DC, 2009. (c) Najera, C.;
Sansano, J. M. Chem. Rev. 2007, 107, 4584-4671.
g.cm3, F(0
0 0) = 356, crystal size: 0.51 x 0.13 x 0.12 mm.
Crystallographic data (excluding structure factors) for these compounds
have been deposited with the Cambridge Crystallographic Data Centre as
supplementary publication numbers CCDC 898280 for 2j, CCDC
898281 for 3j and CCDC 898282 for 6j. These data can be obtained free
of charge from The Cambridge Crystallographic Data Centre via
2. (a) Wang, J.; Liu, X.; Feng, X. Chem. Rev. 2011, 111, 6947-6983. (b)
Merino, P.; Marques-Lopez, E.; Tejero, T.; Herrera, R. P. Tetrahedron,
2009, 65, 1219-1234. (c) Gawronski, J.; Wascinska, N.; Gajewy, J.
Chem. Rev. 2008, 108, 5227-5252.
3. For some recent references, see: (a) Rajabi, F.; Nourian, S.; Ghiassian,
S.; Balu, A. M.; Saidi, M. R.; Serrano-Ruiz, J. C.; Luque, R. Green
Chem. 2011, 13, 3282-3289. (b) Cherian, J.; Choi, I.-H.; Nayyar, A.;
Manjunatha, U. H.; Mukherjee, T.; Lee, Y-S.; Boshoff, H. I.; Singh, R.;
Ha, Y-H; Goodwin, M.; Lakshminarayana, S. B.; Niyomrattanakit, P.;
Jiricek, J.; Ravindran, S.; Dick, T.; Keller, T. H.; Dartois, V.; Barry, C.
E. J. Med. Chem. 2011, 54, 5639-5659. (c) Ouizem, S.; Cheramy, S.;
Botuha, C.; Chemla, F.; Ferreira, F.; Perez-Luna, A. Chem. Eur. J. 2010,
16, 12668-12677. (d) Reddy, B. M.; Thirupathi, B.; Patil, M. K. J. Mol.
Catal. A: Chem. 2009, 307, 154-159. (e) Filosa, R.; Fulco, M. C.;
Marinozzi, M.; Giacche, N.; Macchiarulo, A.; Peduto, A.; Massa, A.; de
Caprariis, P.; Thomsen, C.; Christoffersen, C. T.; Pellicciari, R. Bioorg.
Med. Chem. 2009, 17, 242-250. (f) Mojtahedi, M. M.; Abaee, M. S.;
Alishiri, T. Tetrahedron Lett. 2009, 50, 2322-2325.
4. (a) Montalban, A. G. Heterocycles in Natural Product Synthesis Ed.,
Wiley-VCH., New York, 2011, pp 299-339. (b) Wang, X.-J.; Gong, D.-
L.; Wang, J.-D.; Zhang, J.; Liu, C.-X.; Xiang, W.-S. Bioorg. Med. Chem.
Lett. 2011, 21, 2313-2315. (c) Michael, J. P. Nat. Prod. Rep. 2007, 24,
223-246. (d) Kumar A.; Katiyar S.B.; Agarwal A.; Chauhan P.M.S. Curr.
Med. Chem. 2003, 10, 1137-1150.
5. (a) Alajarin, R.; Burgos, C. J. Modern Heterocyclic Chemistry, Ed.,
Wiley-VCH., New York, 2011, pp 1527-1629. (b) Dietrich, S. A.;
Lindauer, R.; Stierlin, C.; Gertsch, J.; Matesanz, R.; Notararigo, S.; Diaz,
J. F.; Altmann, K.-H. Chem. Eur. J. 2009, 15, 10144-10157. (c)
Rodriguez Sarmiento, R. M.; Nettekoven, M. H.; Taylor, S.; Plancher, J.-
M.; Richter, H.; Roche, O. Bioorg. Med. Chem. Lett. 2009, 19, 4495-
4500. (d) Wei, L.; Zhang, Z.-W.; Wang, S.-X.; Ren, S.-M.; Jiang, T.
Chem. Biol. Drug Des. 2009, 74, 80-86. (e) Kouznetsov, V. V.; Gomez-
Barrio, A. Eur. J. Med. Chem. 2009, 44, 3091-3113. (f) Wu, D.
Tetrahedron, 2003, 59, 8649-8687.
6. a) Hayour, H.; Bouraiou, A.; Bouacida S.; Berrée, F.; Carboni, B.; Roisnel,
T.; Belfaitah, A. Tetrahedron Lett. 2011, 52, 4868-4871. (b) Bouraiou,
A.; Berrée, F.; Bouacida, S.; Carboni, B.; Debache, A.; Roisnel, T.;
Belfaitah, A. Lett. Org. Chem. 2011, 8, 374-377. (c) Bouraiou, A.;
Debache, A.; Rhouati, S.; Benali-Cherif, N.; Carboni, B.; Belfaitah, A.
Open Org. Chem. J. 2010, 4, 1-7. (d) Bouraiou, A.; Debache, A.;
Rhouati, S.; Carboni, B.; Belfaitah, A. J. Heterocycl. Chem. 2008, 45,
329-333. (e) Menasra, H.; Kedjadja, A.; Rhouati, S.; Carboni, B.;
Belfaitah, A. Synth. Commun. 2005, 35, 2779-2788.
14. Belfaitah, A.; Ladraa, S.; Bouraiou, A.; Benali-Cherif, N.; Debache, A.;
Rhouati, S. Acta Cryst. 2006, E62, o1355.
15. Selected properties and spectral data for (R)-2-(2-chloroquinolin-3-yl)-2-
[N-[(S)--methylbenzylamino]acetonitrile (+)-3j: White crystals; mp.
1
145-146 °C. []D20= + 9.6 (c=1.0, CH2Cl2). H (300 MHz, CDCl3): 8.31
(s, 1H), 8.05 (d, J =8.4 Hz, 1H), 7.95-7.75 (m, 2H), 7.71 (d, J =8.0 Hz,
1H), 7.45-7.20 (m, 5H), 5.25 (d, J =9.6 Hz, 1H), 4.12 (q, J =6.4 Hz, 1H),
2.08 (d, J =9.6 Hz, 1H), 1.51 (d, J =6.4 Hz, 3H). 13C NMR (75.4 MHz,
CDCl3): 148.9, 147.4, 143.5, 141.9, 137.9, 131.4, 128.7, 128.3, 127.8,
127.7, 126.8, 126.7, 126.6, 117.7, 56.6, 49.9, 22.7. Anal. Calcd for
C19H16ClN3: C, 70.91; H, 5.01; N, 13.06. Found: C, 71.17; H, 4.99; N,
13.22.
16. Selected properties and spectral data for (R)-2-(2-chloroquinolin-3-yl)-2-
20
[N-(S)--methylbenzylamino]carboxamide (-)-6j: 65% yield. []D = -
139.5 (c 1.08, CH2Cl2). IR max (KBr) 3344, 1508 cm-1. 1H NMR (300
MHz, CDCl3): 7.89 (d, J = 8.5 Hz, 1H), 7.82 (s, 1H), 7.66 (d, J = 8.2 Hz,
1H), 7.60 (td, J =8.4, 1.5 Hz, 1H), 7.43 (td, J =8.4, 1.1 Hz, 1H), 7.25-715
(m, 5H), 6.74 (br s, 1H), 4.23 (s, 1H), 3.50 (q, J = 6.5 Hz, 1H), 1.21 (d, J
= 6.5 Hz, 3H). 13C NMR (75.47 MHz, CDCl3): 173.2, 149.3, 147.0,
143.2, 140.0, 130.7, 130.0, 128.9, 128.2, 127.7, 127.5, 126.9, 62.3, 55.9,
24.1. HRMS : m/z [M+Na]+ Calcd. for C19H18N3OClNa: 362.1036;
found: 362.1035.
17. Procedure for derivatization of 8j with O-acetyl-(R)-mandelic acid.
To a solution of O-acetyl-(R)-mandelic acid (7 mg, 0.037 mmol) in dry
CH2Cl2 (1 mL), were added, at 0 °C, EDCI (9 mg, 0.048 mml), HOBT (6
mg, 0.045 mmol) and N-methylmorpholine (16 mL, 0.14 mmol). After
30 min at 0 °C, a solution of 8j (10 mg, 0.037 mmol) in dry CH2Cl2 (1
mL) was added to the reaction mixture. The reaction was stirred at rt
overnight then Et2O (3 mL) was added. The organic phase was washed
with 0.1 M HCl (3x1 mL), H2O (2x1 mL), brine (1 mL) then dried,
filtered and concentrated under reduced pressure to give the
corresponding product as a mixture of two diastereomers (ratio: 70/30).
Characteristic signals for the major diastereomer : 1H NMR (500 MHz,
CDCl3): 6.20 (s, 1H), 5.58 (d, J = 8.4 Hz, 1H), 3.73 (s, 3H).
Characteristic signals for the minor diastereomer : 1H NMR (500 MHz,
CDCl3): 6.15 (s, 1H), 5.71 (d, J = 8.5 Hz, 1H), 3.76 (s, 3H).
18. Selected properties and spectral data for (R)-2-(1,2-dihydro-2-
20
7. Datta, N. J.; Khunt, R. C.; Parikh, A. R. Ind. J. Chem. 2002, 41B, 433-
435.
8. Atherton, J. H.; Blacker, J.; Crampton, M. R.; Grosjean, C. Org. Biomol.
Chem. 2004, 2, 2567-2571.
oxoquinolin-3-yl)-2-aminomethyl acetate (-)-8j. 92% yield. []D = -
52.8 (c 0.75, MeOH). IR max (KBr) 1749, 1652 cm-1. 1H NMR (400
MHz, MeOD): 8.28 (s, 1H), 7.80 (d, J = 7.8 Hz, 1H), 7.67 (t, J = 7.7 Hz,
1H), 7.44 (d, J = 7.9 Hz, 1H), 7.36 (t, J = 7.6 Hz, 1H), 5.29 (s, 1H), 3.86
(s, 3H). 13C NMR (100 MHz, MeOD): 170.1, 163.7, 145.3, 141.1, 134.1,
130.8, 125.9, 125.3, 121.4, 117.6, 55.6, 55.0. HRMS : m/z [M+H]+
Calcd. for C12H13N2O3: 233.0926; found: 233.0927.
9. Curreli, F.; Zhang, H.; Zhang, X.; Pyatkin, I.; Victor, Z.; Altieri, A.;
Debnath, A. K. Bioorg. Med. Chem. 2011, 19, 77-90.
10. Selected spectral data for 2-benzylamino-2-(1,2-dihydro-6-methyl-2-
oxoquinolin-3-yl)acetic acid hydrochloride 5h. White solid. mp 218 °C.
IR max (KBr) 3421, 1743, 1651 cm-1. 1H NMR (250 MHz, DMSO-d6):
12.20 (br s, 1H), 9.60-10.00 (br s, 2H), 8.06 (s, 1H), 7.65-7.20 (m, 8H),
5.14 (s, 1H), 4.17 (s, 2H), 2.34 (s, 3H). 13C NMR (62.9 MHz, DMSO-d6):
168.6, 161.0, 142.4, 137.2, 133.3, 132.1, 131.7, 130.7, 130.7, 129.4,
128.9, 128.9, 128.2, 123.6, 118.7, 115.7, 58.2, 49.8, 20.7. HRMS (ESI):
m/z [M – HCl + Na]+ Calcd for C19H18N2O3Na: 345.1215. Found:
345.1212.
11. Truong, M.; Lecornué, F.; Fadel, A. Tetrahedron: Asymmetry 2003, 14,
1063-1072.
12. Katritzky, A. R.: Latif, M.; Noble, G.; Harris, P. Synthesis 1990, 999-
1001.
19. Ladraa, S.; Bouraiou, A.; Bouacida, S.; Roisnel T.; Belfaitah, A. Acta
Cryst. 2009, C65, o475-o478.
20. (a) Ladraa, S.; Bouraiou, A.; Bouacida, S.; Roisnel T.; Belfaitah, A. Acta
Cryst. 2010, E66, o693. (b) Leleu, S.; Papamicael, C.; Marsais, F.;
Dupas, G. Levacher, V. Tetrahedron: Asymmetry, 2004, 15, 3919-3928.
21. While this work was in progress, it was shown that treatment of (S,S)-α-
aminonitriles derived from (S)-1-(4-methoxyphenyl)ethylamine and
arylaldehydes in 6 M aqueous HCl at reflux resulted in cleavage of their
chiral auxiliary fragments and concomitant hydrolysis of their nitrile
groups. Perez-Fuertes, Y.; Taylor, J. E.; Tickell, D. A.; Mahon, M. F.;
Bull, S. D.; James, T. D. J. Org. Chem. 2011, 76, 6038-6047.
13. Crystal structure analysis for 2-chloro-3-[(S)--methylbenzylimino]
methylquinoline (2j): C18H15ClN2, Mr = 294,7 g.mol-1, monoclinic, space
group P21(4), a = 8.0353 (3) Ǻ, b = 13.7059 (6) Ǻ, c = 13.4665 (6) Ǻ, =
94.717 (2)°, V = 1478.06 (11) Å3, Z = 4, c= 1.325 g.cm3, F(0 0 0) = 616,
crystal size: 0.24 x 0.13 x 0.03 mm. Crystal structure analysis for (R)-2-
(2-chloroquinolin-3-yl)-2-[N-[(S)--methylbenzylamino]acetonitrile (3j):
C19H16ClN3, Mr = 321.8 g.mol-1, orthorhombic, space group P212121(19),